415 Results

People

  1. Herr
    Herr
  2. Russo
    Russo
  3. Dalbagni
    Dalbagni
  4. Motzer
    Motzer
  5. Bochner
    Bochner
  6. Donat
    Donat
  7. Eastham
    Eastham
  8. D'Angelica
    D'Angelica
  9. DeMatteo
    DeMatteo
  10. Vickers
    Vickers

Groups

  1. Surgery (238)
  2. Urology (162)
  3. Department of Medicine (114)
  4. Solid Tumor Oncology Division (89)
  5. Survivorship Research (85)
  6. Epidemiology and Biostatistics (68)
  7. Population Sciences Research Program (58)
  8. Center for Pancreatic Cancer Research (48)
  9. Genitourinary Oncology Service (48)
  10. Sloan Kettering Institute Faculty (47)
  1. "follow up"
  2. "Elsevier Science, Inc."
Formats
  1. Journal Article (399)
  2. Correspondence (5)
  3. Editorial (4)
  4. Guidelines (2)
  5. Research Letter (2)
  6. Review (2)
  7. Conference Paper (1)
Groups
  1. Surgery (238)
  2. Urology (162)
  3. Department of Medicine (114)
  4. Solid Tumor Oncology Division (89)
  5. Survivorship Research (85)
  6. Epidemiology and Biostatistics (68)

More Groups

People
  1. Harry Herr (42)
  2. Paul Russo (32)
  3. Peter Scardino (29)
  4. Guido Dalbagni (28)
  5. Michael Zelefsky (25)
  6. Robert Motzer (23)

More People

Years
  1. 2024 (6)
  2. 2023 (20)
  3. 2022 (15)
  4. 2021 (14)
  5. 2020 (28)
  6. 2019 (20)

More Years

Publications
  1. Journal of Urology (88)
  2. European Urology (70)
  3. Urology (47)
  4. Lancet Oncology (45)
  5. Journal of the American College of Surgeons (30)
  6. Brachytherapy (17)

More Publications

Publishers
  1. Elsevier Science, Inc. (415)

Results (415)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Three-dimensional margin as a predictor of local tumor progression after microwave ablation: Intraprocedural versus 4–8-week postablation assessment
    Journal Article

    Zirakchian Zadeh, M.; Sotirchos, V. S.; Kirov, A.; Lafontaine, D.; Gönen, M.; Yeh, R.; Kunin, H.; Petre, E. N.; Kitsel, Y.; Elsayed, M.; more...
    Journal of Vascular and Interventional Radiology (2024)

    Fulltext@MSK | Save
  • Effects of androgen deprivation therapy on prostate cancer outcomes according to competing event risk: Secondary analysis of a phase 3 randomised trial
    Journal Article

    Mell, L. K.; Pugh, S. L.; Jones, C. U.; Nelson, T. J.; Zakeri, K.; Rose, B. S.; Zeitzer, K. L.; Gore, E. M.; Bahary, J. P.; Souhami, L.; more...
    European Urology (2024)

    Fulltext@MSK | Save
  • Health-related quality of life in patients with triple-class exposed relapsed and refractory multiple myeloma treated with idecabtagene vicleucel or standard regimens: patient-reported outcomes from the phase 3, randomised, open-label KarMMa-3 clinical trial
    Journal Article

    Delforge, M.; Patel, K.; Eliason, L.; Dhanda, D.; Shi, L.; Guo, S.; Marshall, T. S.; Arnulf, B.; Cavo, M.; Nooka, A.; more...
    The Lancet Haematology (2024)

    Fulltext@MSK | Save
  • Incidence, predictors, and impact of hospital readmission after revascularization for left main coronary disease
    Journal Article

    Kosmidou, I.; Shahim, B.; Dressler, O.; Redfors, B.; Morice, M. C.; Puskas, J. D.; Kandzari, D. E.; Karmpaliotis, D.; Brown, W. M. 3rd; Lembo, N. J.; more...
    Journal of the American College of Cardiology (2024)

    Fulltext@MSK | Save
  • Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): An open-label, randomised, controlled, phase 2 study
    Journal Article

    Tsai, C. J.; Yang, J. T.; Shaverdian, N.; Patel, J.; Shepherd, A. F.; Eng, J.; Guttmann, D.; Yeh, R.; Gelblum, D. Y.; Namakydoust, A.; more...
    Lancet (2024)

    Fulltext@MSK | Save
  • Second malignancy probabilities in patients with breast cancer treated with conventional versus hypofractionated external beam radiation therapy in the adjuvant setting
    Journal Article

    Patel, T. A.; Jain, B.; Cho, H. L.; Corti, C.; Vapiwala, N.; Chino, F.; Leeman, J. E.; Dee, E. C.
    Clinical Oncology (2024)

    Fulltext@MSK | Save
  • In-utero diagnosis of prostatic embryonal rhabdomyosarcoma
    Journal Article

    Schiller, E.; Joshi, P.; El-Ali, A.; Brenseke, W.; Magid, M. S.; Wexler, L.; Gitlin, J.
    Urology (2023)

    Fulltext@MSK | Save
  • Relationship between baseline prostate-specific antigen on cancer detection and prostate cancer death: Long-term follow-up from the European Randomized Study of Screening for Prostate Cancer
    Journal Article

    Remmers, S.; Bangma, C. H.; Godtman, R. A.; Carlsson, S. V.; Auvinen, A.; Tammela, T. L. J.; Denis, L. J.; Nelen, V.; Villers, A.; Rebillard, X.; more...
    European Urology (2023)

    Fulltext@MSK | Save
  • First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: A single-arm, single-centre, phase 2 trial
    Journal Article

    Cytryn, S. L.; Moy, R. H.; Cowzer, D.; Shah, R. H.; Chou, J. F.; Joshi, S. S.; Ku, G. Y.; Maron, S. B.; Desai, A.; Yang, J.; more...
    Lancet Oncology (2023)

    Fulltext@MSK | Save
  • Addition of daratumumab to lenalidomide, bortezomib, and dexamethasone for transplantation-eligible patients with newly diagnosed multiple myeloma (GRIFFIN): Final analysis of an open-label, randomised, phase 2 trial
    Journal Article

    Voorhees, P. M.; Sborov, D. W.; Laubach, J.; Kaufman, J. L.; Reeves, B.; Rodriguez, C.; Chari, A.; Silbermann, R.; Costa, L. J.; Anderson, L. D. Jr; more...
    The Lancet Haematology (2023)

    Fulltext@MSK | Save